Vectorite Biomedical

Vectorite Biomedical Tax Expense

Income Tax Expense of Vectorite Biomedical (4170.TWO) as of Nov 5, 2026.

Tax Expense

0.00TWD

Last updated:

Income Tax Expense of Vectorite Biomedical is 2025 0.00 TWD. Income Tax Expense of Vectorite Biomedical was 2024 0.00 TWD. It decreases by % lower compared to the previous year.

The Vectorite Biomedical Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2017
0.00 TWD
Jan 1, 2018
828,000.00 TWD
Jan 1, 2019
-9.67 M TWD
Jan 1, 2021
-29,000.00 TWD
Jan 1, 2022
-41,000.00 TWD
Jan 1, 2023
0.00 TWD
Jan 1, 2024
0.00 TWD
Jan 1, 2025
0.00 TWD
The Vectorite Biomedical Tax Expense history
YEARTax ExpenseYoY
0.00TWD—
0.00TWD—
0.00TWD-100.00%
-41,000.00TWD+41.38%
-29,000.00TWD-99.70%
-9.67 MTWD-1,267.51%
828,000.00TWD—
0.00TWD-100.00%
21,000.00TWD+90.91%
11,000.00TWD-99.81%
5.81 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Xinpin Biomedical Co., Ltd. established Xinpin Biomedical Group with the concept of “preventing problems before it happens” and is headquartered in Taipei, New Taipei. The firm offers a range of services including immune cell collection, processing and storage, cell preparation safety testing, anti-cancer immunity testing, original design manufacturer or contract development and manufacturing organization services, related medical consulting, and laboratory quality management. Its product portfolio features dendritic cell vaccines and natural killer cell preparations designed for cancer treatment. Products are mainly sold domestically. Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

On Eulerpool you can find the complete historical development of Income Tax Expense Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Vectorite Biomedical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vectorite Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vectorite Biomedical